Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A framework for integrating continuous therapeutic monitoring and the development of AI for clinical care may improve patient and health-system outcomes by tightening feedback loops between patient health, clinical interactions and the development of AI models.
This Perspective discusses progress in the development of robotic capsules for oral drug delivery and the challenges of realizing sophisticated multifunctional robotic pills that can function as closed-loop systems.
This Perspective argues that dermal interstitial fluid cannot be generally considered a diagnostically useful proxy for blood, yet that it can offer advantageous utility for the monitoring of therapeutic drugs and of the status of the immune system.